Neoplasms, Germ Cell and Embryonal  >>  Torisel (temsirolimus)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Torisel (temsirolimus) / Pfizer
NCT00800917 / 2008-003679-40: A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

Completed
2
12
Europe
Temsirolimus, Bevacizumab
Rigshospitalet, Denmark, University of Copenhagen, Wyeth is now a wholly owned subsidiary of Pfizer, Roche, Copenhagen
Glioblastoma Multiforme
02/10
02/10
NCT01019434 / 2008-003003-31: Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
111
Europe
temozolomide, temsirolimus
European Organisation for Research and Treatment of Cancer - EORTC, Pfizer
Brain and Central Nervous System Tumors
12/13
03/14

Download Options